VertiFlex will focus attentions on the Superion product line, which is currently scheduled for upcoming clinical trials. The Superion Interspinous Spacer is a percutaneous titanium implant fitting between the spinous processes in the lumbar spine.
Read the VertiFlex news release on the sale of the Silverbolt product portfolio.
Read other coverage on VertiFlex:
– VertiFlex Announces 100th Patient Enrolled in Superion IDE Trial
– Dr. George Rappard First in the U.S. to Present Superion Interspinous Spacer Clinical Results
– Spine Surgeon First in Pennsylvania to Implant Device to Treat Leg Pain Caused by Spinal Stenosis
